Hester Biosciences Ltd — Capital/Financing Update 2021

Nov 13, 2021

==> picture [595 x 128] intentionally omitted <==

13 November 2021

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 524669 Symbol: HESTERBIO

Dear Sir/ Madam:

Subject: Outcome of Board Meeting

This is with reference to our letter dated 10 November 2021 intimating the date of the Board Meeting for consideration of the borrowings of additional funds as a loan to meeting capex and investment requirements of the Company.

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the Approved borrowings as a loan by way of External Commercial Borrowing (ECB) to the extent of USD 12 million as per the guidelines/directions issued by Reserve Bank of India.

The Board Meeting commenced at 11:46 a.m. (IST) and concluded at 12:00 p.m. (IST)

You are requested to take the above information on your record.

Sincerely, For Hester Biosciences Limited

==> picture [76 x 37] intentionally omitted <==

Vinod Mali Company Secretary & Compliance Officer